Heterogeneity of KRAS Mutation Status in Rectal Cancer

INTRODUCTION: Anti-EGFR targeted therapy is of increasing importance in advanced colorectal cancer and prior KRAS mutation testing is mandatory for therapy. However, at which occasions this should be performed is still under debate. We aimed to assess in patients with locally advanced rectal cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Jo, Peter, König, Alexander, Schirmer, Markus, Kitz, Julia, Conradi, Lena-Christin, Azizian, Azadeh, Bernhardt, Markus, Wolff, Hendrik A., Grade, Marian, Ghadimi, Michael, Ströbel, Philipp, Schildhaus, Hans-Ulrich, Gaedcke, Jochen
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4827807/
https://ncbi.nlm.nih.gov/pubmed/27064574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0153278
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados